Ms. Nikki Nelson Sayer, LPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 946 W Baseline Rd, Paul, ID 83347 Phone: 208-438-2305 |
Shanna L Lindsay, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 518 E Idaho St, Paul, ID 83347 Phone: 208-670-0156 |
News Archive
Ohr Pharmaceutical, Inc., a pharmaceutical company focused on the development of novel therapeutics for large unmet medical needs, today announced that it has enrolled the first 60 patients in the Company's ongoing OHR-002 Phase II clinical trial evaluating Squalamine Eye Drops for the treatment of the wet form of age-related macular degeneration.
Melinda Sothern, PhD, CEP, Professor of Public Health and Director of Health Promotion at LSU Health Sciences Center New Orleans, will present evidence that supports relationships seen in adolescents between insulin sensitivity and fatty liver, belly fat, and total body fat and identifies additional potential early markers of insulin resistance and metabolic syndrome in healthy 7-9 year-old children, including fat in muscle cells, blood pressure, physical activity, and birth weight.
Topokine Therapeutics has initiated dosing in a Phase 2, randomized controlled clinical trial of XAF5 Gel for reduction of excess submental fat, commonly known as "double chin." XAF5 Gel is a proprietary skin formulation of a compound already known to reduce fat around the human eye. Study participants are applying XAF5 Gel or placebo once a night to skin under the chin.
Sandwiches make up a substantial part of the American diet and are a significant contributor to daily energy and sodium intake. By closely analyzing data from the federal nationwide dietary intake survey known as "What We Eat in America NHANES 2009-2010," a team of Department of Agriculture researchers found that on any given day 49 percent of U.S. adults eat at least one sandwich, and sandwiches account for one-fifth of total daily sodium intake.
› Verified 4 days ago